Anti-Human IL23 Therapeutic Antibody (Tildrakizumab)

Recombinant humanized (from mouse) antibody expressed in CHO binding to human IL23. Tildrakizumab is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.
Supplier Creative Biolabs
Product # TAB-875
Pricing Inquiry
Host Mouse
Target IL23
Species Reactivity Human
Type IgG1 - kappa
Applications Neut, ELISA, IF, IP, FuncS, FC, ICC
Storage At -20°C for one year.
Feedback